Analysis of Next Generation Protein Biopharmaceuticals

This webcast will focus on next generation biopharmaceuticals, for example, biosimilars, biobetters, and antibody drug conjugates. We will look at how chromatographic and mass spectrometric techniques can be used to distinguish differences between originator and next generation biopharmaceuticals and which properties are assigned as critical quality attributes (CQAs).

Topics include:

• What are next generation protein biopharmaceuticals?
• Biosimilars - How similar is similar enough?
• Biosimilars versus biobetters - distinguishing similar from better
• Analytical tools for assessing similarity
• Techniques for analyzing bispecific antibody drug conjugates
• MS based techniques for the comparison of originator, biosimilar, and biobetter antibodies